$392.33+0.65 (+0.17%)
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
HCA Healthcare, Inc. in the Healthcare sector is trading at $392.33 with a market capitalization of $88.3B. Wall Street consensus targets $500.29 (21 analysts), implying a +27.5% move over the next 12 months. The stock is currently 30% below its 52-week high of $556.52, remaining 14.4% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $19.11B↓ | $19.51B↑ | $19.16B↑ | $18.61B↑ | $18.32B |
| Gross Profit | $7.97B↓ | $8.18B↑ | $8.02B↑ | $7.62B↑ | $7.56B |
| Operating Income | $2.86B↓ | $3.18B↑ | $2.96B | $2.97B↑ | $2.85B |
| Net Income | $1.62B↓ | $1.88B↑ | $1.64B↓ | $1.65B↑ | $1.61B |
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic a...
EHC is accelerating hospital and bed expansions to boost capacity, with execution now key as stronger results support higher 2026 EPS guidance.
HCA Healthcare, Inc. (NYSE:HCA) is one of the best non-tech stocks to buy according to analysts. TD Cowen cut the price target on HCA Healthcare, Inc. (NYSE:HCA) to $431 from $500 on June 22 and maintained a Buy rating on the shares. The firm told investors in a research note that it reduced the company’s 2026 and […]
As a wise man once said, it's important to "be greedy when others are fearful."
With shares lagging and revenue growth slowing, the market seems to be missing the powerful engine driving HCA's per-share earnings higher.
CYH has cut billions in debt, but can improving operations keep the turnaround alive and ease leverage concerns?